Zimmer Biomet Holdings, Inc. ZBH
91.04
1.35
1.51%
as of 25 Sep
- Market cap
- $17.1B
- P/E
- 22.0×
Follow ZBH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Zimmer Biomet Holdings, Inc. (ZBH) P/S ratio
As of 25 September 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a P/S ratio of 2.1×. Over the past ten years it has ranged from 1.8× (May 2026) to 6.1× (April 2021); the current reading is higher than 2% of that period. That is below the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 2.2× | (22.58%) |
| FY2024 | 2.8× | (18.45%) |
| FY2023 | 3.4× | (10.87%) |
| FY2022 | 3.8× | 2.01% |
| FY2021 | 3.8× | (25.43%) |
| FY2020 | 5.1× | 35.35% |
| FY2019 | 3.7× | 44.55% |
| FY2018 | 2.6× | (17.11%) |
| FY2017 | 3.1× | 19.11% |
| FY2016 | 2.6× | (15.92%) |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 1.9× | (7.26%) |
| Mar 2026 | 2.1× | (3.06%) |
| Dec 2025 | 2.2× | (11.20%) |
| Sep 2025 | 2.4× | 5.71% |
| 42 more quarters | Free account |
Against its own ten years
Low 1.8×
High 6.1×
Ten-year median
3.2×
Current reading's percentile
2
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 1.2× |
| PHG Koninklijke Philips N.V. compare | 1.2× |
| GEHC GE HealthCare Technologies Inc. compare | 1.4× |
| ZBH Zimmer Biomet Holdings, Inc. | 2.1× |
| GMED Globus Medical, Inc. compare | 3.2× |
| STE STERIS plc compare | 3.4× |
| BIO.B Bio-Rad Laboratories, Inc. compare | 3.8× |
| BIO Bio-Rad Laboratories, Inc. compare | 3.9× |
| PEN Penumbra, Inc. compare | 8.3× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on ZBH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement